NEW YORK – Personalis said today that it will employ its ImmunoID NeXT platform in an ovarian cancer study spearheaded by the University of New Mexico Comprehensive Cancer Center and the New Mexico Alliance for Cancer Care.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Don't have a GenomeWeb or 360Dx account?Register for Free.
This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.
This webinar will discuss what it takes to begin realizing precision medicine in a comprehensive clinical infrastructure, with insights from the Colorado Center for Personalized Medicine (CCPM).
This webinar will address how two molecular laboratories are implementing tertiary analysis software to improve their precision oncology workflows.